Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 2 ... Scientists discuss in 'Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy' new findings in...
2009 AUG 31 ... publish new data in the report 'Risk factors for severe infection in patients with hairy cell leukemia: a long-term study of 73 patients.' According to a study from Amiens, France, ...
2009 NOV 2 ... Current study results from the report, 'Approach to the patient after relapse of hairy cell leukemia,' have been published. According to recent research from the United States, "The ...
2009 APR 20 ... concluded: "The most successful application of recombinant immunotoxins today is in hairy cell leukemia, where BL22 has induced complete remissions in most patients who were previously treated ...
2009 SEP 7 ... Lymphocytic Leukemia or Chronic Myelogenous Leukemia or Acute Myelogenous Leukemia or Hairy Cell Leukemia Therapy Area Pipeline Report" report to their offering. Life Science ...
2009 OCT 5 ... in the absence of c-Maf rearrangement. In contrast, c-Maf was strongly expressed in hairy cell leukemia (4/4) and in a significant proportion of T-cell (24/42 [57%]) and NK/T-cell (49/97 ...
2009 MAY 4 ... "CD 103 is characteristically expressed in hairy cell leukemia (HCL), a B-lymphoproliferative disorder highly responsive to treatment with purine ...
2009 AUG 3 ... in the United States conducted a study "To conduct a phase II trial in chemoresistant hairy cell leukemia (HCL) with BL22, a recombinant anti-CD22 immunotoxin which showed phase I activity in ...
2009 FEB 9 ... Investigators publish new data in the report 'PRAME expression in hairy cell leukemia.' According to a study from the United States, "PRAME has been proposed as a ...
2009 NOV 2 ... A new study, 'Combination therapies to improve the long-term outcome in hairy cell leukemia,' is now available. "Since its first description in 1958,...
2009 JUN 29 ... B-cell NHL specifically lymphoplasmacytic lymphoma/Waldenstrom macroglobulinemia and hairy cell leukemia. No excesses of aggressive B-cell or T-cell lymphomas were found. There was no ...
2009 NOV 2 ... New investigation results, 'The biology of hairy cell leukemia,' are detailed in a study published in Leukemia & Lymphoma. "As in all malignancies, ...
2009 NOV 9 ... "Progress in the treatment of patients with hairy cell leukemia (HCL) has led to a significant change in the natural history of the disease. With ...
2009 NOV 2 ... A new study, 'Cladribine in the treatment of hairy cell leukemia: initial and subsequent results,' is now available. According to recent research ...
2009 JUN 15 ... According to recent research from the United States, "Hairy cell leukemia (HCL) is a rare disorder that occasionally has visual symptoms after diagnosis. The ...
2009 NOV 1 ... "The VA's establishment of exposure to Agent Orange as a contributor to hairy cell leukemia (HCL) -- a rare form of cancer -- Parkinson's disease and ischemic heart disease (IHD) ...
2009 NOV 1 ... The illnesses affected by the recent decision are B cell leukemias, such as hairy cell leukemia; Parkinson's disease; and ischemic heart disease. Used in Vietnam to ...
